Skip to content

Drug interactions

Fosamprenavir + Lidocaine

Severity: Moderate

Fosamprenavir and Lidocaine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosamprenavir (as amprenavir) inhibits CYP3A4, which contributes to lidocaine metabolism. Systemic lidocaine levels may rise, increasing the risk of toxicity such as dizziness, seizures and cardiac effects, particularly with intravenous or repeated dosing.

What this interaction means in plain words

Fosamprenavir and Lidocaine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Amprenavir inhibits CYP3A4-mediated lidocaine metabolism.

What to do

Monitor for signs of lidocaine toxicity and consider reducing the dose or infusion rate when systemic lidocaine is needed. Local anesthetic use at usual doses generally needs no change.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fosamprenavir and Lidocaine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fosamprenavir with Lidocaine?

MediHelp rates the interaction as moderate. Fosamprenavir and Lidocaine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fosamprenavir (as amprenavir) inhibits CYP3A4, which contributes to lidocaine metabolism. Systemic lidocaine levels may rise, increasing the risk of toxicity such as dizziness, seizures and cardiac effects, particularly with intravenous or repeated dosing.

How serious is the interaction between Fosamprenavir and Lidocaine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of lidocaine toxicity and consider reducing the dose or infusion rate when systemic lidocaine is needed. Local anesthetic use at usual doses generally needs no change.

What other medicines interact with Lidocaine?

MediHelp also lists interactions of Lidocaine with, for example, Bupivacaine liposome, Disopyramide, Ex vivo expanded autologous human corneal epithelial cells containing stem cells. The full list is on the Lidocaine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in